Drug class
Injectable iron is a therapeutic class of parenteral mineral replacement agents formulated as colloidal iron-carbohydrate nanoparticle complexes. Read more about Iron, Injectable
23 drugs in this class 17 manufacturers
Injectable iron is a therapeutic class of parenteral mineral replacement agents formulated as colloidal iron-carbohydrate nanoparticle complexes.
Administered intravenously or intramuscularly, these agents are taken up by cells of the reticuloendothelial system, where elemental iron is dissociated and incorporated into physiologic storage and transport proteins—such as ferritin and transferrin—to support red blood cell erythropoiesis and replenish depleted systemic iron stores.
This class is primarily indicated for the treatment of iron deficiency anemia in clinical settings where oral iron is ineffective, poorly tolerated, or unfeasible, prominently including chronic kidney disease, inflammatory bowel disease, heart failure, and ongoing or severe blood loss.
Injectable iron is a therapeutic class of parenteral mineral replacement agents formulated as colloidal iron-carbohydrate nanoparticle complexes
Administered intravenously or intramuscularly, these agents are taken up by cells of the reticuloendothelial system, where elemental iron is dissociated and incorporated into physiologic storage and transport proteins—such as ferritin and transferrin—to support red blood cell erythropoiesis and replenish depleted systemic iron stores
Administered intravenously or intramuscularly, these agents are taken up by cells of the reticuloendothelial system, where elemental iron is dissociated and incorporated into physiologic storage and transport proteins—such as ferritin and transferrin—to support red blood cell erythropoiesis and replenish depleted systemic iron stores
This class is primarily indicated for the treatment of iron deficiency anemia in clinical settings where oral iron is ineffective, poorly tolerated, or unfeasible, prominently including chronic kidney disease, inflammatory bowel disease, heart failure, and ongoing or severe blood loss
This class is primarily indicated for the treatment of iron deficiency anemia in clinical settings where oral iron is ineffective, poorly tolerated, or unfeasible, prominently including chronic kidney disease, inflammatory bowel disease, heart failure, and ongoing or severe blood loss
This class is primarily indicated for the treatment of iron deficiency anemia in clinical settings where oral iron is ineffective, poorly tolerated, or unfeasible, prominently including chronic kidney disease, inflammatory bowel disease, heart failure, and ongoing or severe blood loss
This class is primarily indicated for the treatment of iron deficiency anemia in clinical settings where oral iron is ineffective, poorly tolerated, or unfeasible, prominently including chronic kidney disease, inflammatory bowel disease, heart failure, and ongoing or severe blood loss
Following a drug class requires a free Physicians Office Resource account.
